SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...
Covid has largely dropped out of the headlines, but the virus that causes it is still circulating. We ask what we should know about a new variant of SARS-CoV-2, the state of the Covid pandemic in 2025 ...
A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...
News-Medical.Net on MSN
SARS-CoV-2 evolves after jumping from humans to zoo animals
Research on SARS-CoV-2 in zoo tigers, lions, and hyenas shows rapid viral evolution and adaptation, offering insights into cross-species transmission dynamics.
Hosted on MSN
COVID Cases In India Surge 2.5 Times In A Week; All About Variants, Top Symptoms And Everything Else To Know
From 327 confirmed cases on 19 May, active COVID cases in India have gone up to 1009, as per The Ministry of Health and Family Welfare official data. Kerala, Maharashtra and Delhi reported the fastest ...
CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback